TIEFENBACHER GROUP SUMMER EVENT 2023

2 min read

Share this post

Copy Link

For our Tiefenbacher Group Social Day we have given our employees in #hamburg time off so that they can get socially involved in an institution in the Hanseatic city.
We want to promote the common good in our beloved city and therefore supported the Tierpark Hagenbeck (zoo), the Sternbrücke Children’s Hospice, the Stiftung Das Rauhe Haus (child and youth welfare), the alsterdorf assistenz ost (institution for people with disabilities), the Hamburger Tierschutzverein (animal welfare association), and Hanseatic Help e.V. (support for refugees and homeless). Many thanks to all helpers and the organizer Marie-Theres Blumers for your numerous support and the great enthusiasm with which you are committed to your project.

Our culture of caring is essential to achieving our goal of significantly making a difference in the daily lives of people around the world. We will continue to focus on supporting initiatives that are in line with our values and beliefs.

About Tiefenbacher Group– Pioneering Healthcare since 1963 
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines  around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our goal is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.  

For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com 

Tiefenbacher Group - A group of about 20 people poses and smiles outdoors under a rainbow decoration, with trees and a building in the background. The blue border features the "Tiefenbacher Group" logo, highlighting their focus on patient-centric drug development.